Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$45.86 - $54.45 $910,596 - $1.08 Million
-19,856 Reduced 99.17%
167 $9,000
Q4 2022

Jan 31, 2023

SELL
$38.86 - $48.55 $9,287 - $11,603
-239 Reduced 1.18%
20,023 $969,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $754,151 - $2.04 Million
20,262 New
20,262 $770,000
Q2 2022

Jul 25, 2022

BUY
$48.99 - $57.46 $9,895 - $11,606
202 Added 1.12%
18,249 $913,000
Q1 2022

May 09, 2022

BUY
$48.48 - $53.65 $8,096 - $8,959
167 Added 0.93%
18,047 $927,000
Q4 2021

Feb 07, 2022

BUY
$47.07 - $52.35 $18,404 - $20,468
391 Added 2.24%
17,880 $896,000
Q3 2021

Oct 13, 2021

SELL
$47.89 - $53.12 $9,530 - $10,570
-199 Reduced 1.13%
17,489 $843,000
Q2 2021

Jul 26, 2021

BUY
$49.36 - $54.25 $66,043 - $72,586
1,338 Added 8.18%
17,688 $932,000
Q1 2021

May 06, 2021

BUY
$45.46 - $50.51 $93,102 - $103,444
2,048 Added 14.32%
16,350 $809,000
Q4 2020

Jan 20, 2021

SELL
$45.3 - $51.62 $232,706 - $265,171
-5,137 Reduced 26.43%
14,302 $695,000
Q3 2020

Oct 29, 2020

SELL
$49.47 - $53.77 $92,805 - $100,872
-1,876 Reduced 8.8%
19,439 $975,000
Q2 2020

Aug 10, 2020

BUY
$42.91 - $52.5 $237,978 - $291,165
5,546 Added 35.17%
21,315 $1.09 Million
Q1 2020

May 08, 2020

SELL
$38.02 - $51.66 $3.18 Million - $4.32 Million
-83,684 Reduced 84.14%
15,769 $689,000
Q4 2019

Jan 28, 2020

BUY
$44.25 - $50.86 $244,260 - $280,747
5,520 Added 5.88%
99,453 $4.99 Million
Q3 2019

Nov 05, 2019

BUY
$40.34 - $46.64 $221,345 - $255,913
5,487 Added 6.2%
93,933 $4.35 Million
Q2 2019

Jul 30, 2019

BUY
$40.43 - $44.3 $310,825 - $340,578
7,688 Added 9.52%
88,446 $3.83 Million
Q1 2019

Apr 30, 2019

BUY
$40.83 - $45.43 $3.3 Million - $3.67 Million
80,758 New
80,758 $3.58 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.